» Articles » PMID: 37631302

Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 Aug 26
PMID 37631302
Authors
Affiliations
Soon will be listed here.
Abstract

Pain is an unpleasant sensory and emotional experience that affects every aspect of a patient's life and which may be treated through different pharmacological and non-pharmacological approaches. Analgesics are the drugs most commonly used to treat pain, and in specific situations, the use of opioids may be considered with caution. These drugs, in fact, do not always induce optimal analgesia in patients, and several problems are associated with their use. The purpose of this narrative review is to describe the pharmacological approaches currently used for the management of chronic pain. We review several aspects, from the pain-scale-based methods currently available to assess the type and intensity of pain, to the most frequently administered drugs (non-narcotic analgesics and narcotic analgesics), whose pharmacological characteristics are briefly reported. Overall, we attempt to provide an overview of different pharmacological treatments while also illustrating the relevant guidelines and indications. We then report the strategies that may be used to reduce problems related to opioid use. Specifically, we focus our attention on therapeutic drug monitoring (TDM), a tool that could help clinicians select the most suitable drug and dose to be used for each patient. The actual potential of using TDM to optimize and personalize opioid-based pain treatments is finally discussed based on recent scientific reports.

Citing Articles

Opioid Monitoring in Clinical Settings: Strategies and Implications of Tailored Approaches for Therapy.

Rosendo L, Rosado T, Zandonai T, Rincon K, Peiro A, Barroso M Int J Mol Sci. 2024; 25(11).

PMID: 38892112 PMC: 11173075. DOI: 10.3390/ijms25115925.


Two-year Opioid Prescription Trends in Local Sanitary Agency Naples 3 South, Campania Region, Italy. Descriptive Analyses and AI-based Translational Perspectives.

Cascella M, Capuozzo M, Ferrara F, Ottaiano A, Perri F, Sabbatino F Transl Med UniSa. 2024; 26(1):1-14.

PMID: 38560616 PMC: 10980290. DOI: 10.37825/2239-9747.1047.


Causal effects and immune cell mediators between prescription analgesic use and risk of infectious diseases: a Mendelian randomization study.

Jin Y, Yu X, Li J, Su M, Li X Front Immunol. 2024; 14:1319127.

PMID: 38193081 PMC: 10772142. DOI: 10.3389/fimmu.2023.1319127.

References
1.
Schmidt-Hansen M, Bromham N, Taubert M, Arnold S, Hilgart J . Buprenorphine for treating cancer pain. Cochrane Database Syst Rev. 2015; (3):CD009596. PMC: 6513197. DOI: 10.1002/14651858.CD009596.pub4. View

2.
Dailey D, Vance C, Rakel B, Zimmerman M, Embree J, Merriwether E . Transcutaneous Electrical Nerve Stimulation Reduces Movement-Evoked Pain and Fatigue: A Randomized, Controlled Trial. Arthritis Rheumatol. 2019; 72(5):824-836. PMC: 7188591. DOI: 10.1002/art.41170. View

3.
Musshoff F, Lachenmeier K, Trafkowski J, Madea B, Nauck F, Stamer U . Determination of opioid analgesics in hair samples using liquid chromatography/tandem mass spectrometry and application to patients under palliative care. Ther Drug Monit. 2007; 29(5):655-61. DOI: 10.1097/FTD.0b013e318155a329. View

4.
Beakley B, Kaye A, Kaye A . Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review. Pain Physician. 2015; 18(4):395-400. View

5.
de C Williams A, Craig K . Updating the definition of pain. Pain. 2016; 157(11):2420-2423. DOI: 10.1097/j.pain.0000000000000613. View